Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synergistic Use of Pilocarpine-Brimonidine-Oxymetazoline to Control Presbyopia Symptoms

NCT05006898 is registered in ClinicalTrials.gov with Optall Vision as lead sponsor.

NCT NCT05006898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05006898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synergistic Use of Pilocarpine-Brimonidine-Oxymetazoline to Control Presbyopia Symptoms
Lead sponsor
Optall Vision
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2020
Completion date
July 1, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia